These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 35237989)

  • 21. Effects of Astaxanthin on Reverse Cholesterol Transport and Atherosclerosis in Mice.
    Zou TB; Zhu SS; Luo F; Li WQ; Sun XR; Wu HF
    Biomed Res Int; 2017; 2017():4625932. PubMed ID: 29226138
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of ABCA1 protein degradation promotes HDL cholesterol efflux capacity and RCT and reduces atherosclerosis in mice.
    Huang L; Fan B; Ma A; Shaul PW; Zhu H
    J Lipid Res; 2015 May; 56(5):986-97. PubMed ID: 25761370
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatic lipase- and endothelial lipase-deficiency in mice promotes macrophage-to-feces RCT and HDL antioxidant properties.
    Escolà-Gil JC; Chen X; Julve J; Quesada H; Santos D; Metso J; Tous M; Jauhiainen M; Blanco-Vaca F
    Biochim Biophys Acta; 2013 Apr; 1831(4):691-7. PubMed ID: 23328279
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human paraoxonase 1 overexpression in mice stimulates HDL cholesterol efflux and reverse cholesterol transport.
    Ikhlef S; Berrougui H; Kamtchueng Simo O; Zerif E; Khalil A
    PLoS One; 2017; 12(3):e0173385. PubMed ID: 28278274
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Probucol-Oxidized Products, Spiroquinone and Diphenoquinone, Promote Reverse Cholesterol Transport in Mice.
    Yakushiji E; Ayaori M; Nishida T; Shiotani K; Takiguchi S; Nakaya K; Uto-Kondo H; Ogura M; Sasaki M; Yogo M; Komatsu T; Lu R; Yokoyama S; Ikewaki K
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):591-7. PubMed ID: 26848156
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cilostazol enhances macrophage reverse cholesterol transport in vitro and in vivo.
    Nakaya K; Ayaori M; Uto-Kondo H; Hisada T; Ogura M; Yakushiji E; Takiguchi S; Terao Y; Ozasa H; Sasaki M; Komatsu T; Ohsuzu F; Ikewaki K
    Atherosclerosis; 2010 Nov; 213(1):135-41. PubMed ID: 20723893
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Macrophage, but not systemic, apolipoprotein E is necessary for macrophage reverse cholesterol transport in vivo.
    Zanotti I; Pedrelli M; Potì F; Stomeo G; Gomaraschi M; Calabresi L; Bernini F
    Arterioscler Thromb Vasc Biol; 2011 Jan; 31(1):74-80. PubMed ID: 20966401
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cholesterol Efflux and Reverse Cholesterol Transport: Experimental Approaches.
    Litvinov DY; Savushkin EV; Garaeva EA; Dergunov AD
    Curr Med Chem; 2016; 23(34):3883-3908. PubMed ID: 27516200
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HDL Cholesterol Efflux Capacity: Cardiovascular Risk Factor and Potential Therapeutic Target.
    Bhatt A; Rohatgi A
    Curr Atheroscler Rep; 2016 Jan; 18(1):2. PubMed ID: 26710794
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Angiotensin II reduces macrophage cholesterol efflux: a role for the AT-1 receptor but not for the ABC1 transporter.
    Kaplan M; Aviram M; Knopf C; Keidar S
    Biochem Biophys Res Commun; 2002 Feb; 290(5):1529-34. PubMed ID: 11820795
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Niacin Therapy Increases High-Density Lipoprotein Particles and Total Cholesterol Efflux Capacity But Not ABCA1-Specific Cholesterol Efflux in Statin-Treated Subjects.
    Ronsein GE; Hutchins PM; Isquith D; Vaisar T; Zhao XQ; Heinecke JW
    Arterioscler Thromb Vasc Biol; 2016 Feb; 36(2):404-11. PubMed ID: 26681752
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Seeking novel targets for improving in vivo macrophage-specific reverse cholesterol transport: translating basic science into new therapies for the prevention and treatment of atherosclerosis.
    Julve J; Llaverias G; Blanco-Vaca F; Escolà-Gil JC
    Curr Vasc Pharmacol; 2011 Mar; 9(2):220-37. PubMed ID: 21143175
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HDL and reverse cholesterol transport in humans and animals: Lessons from pre-clinical models and clinical studies.
    Zanotti I; Potì F; Cuchel M
    Biochim Biophys Acta Mol Cell Biol Lipids; 2022 Jan; 1867(1):159065. PubMed ID: 34637925
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aerobic exercise training enhances the in vivo cholesterol trafficking from macrophages to the liver independently of changes in the expression of genes involved in lipid flux in macrophages and aorta.
    Pinto PR; Rocco DD; Okuda LS; Machado-Lima A; Castilho G; da Silva KS; Gomes DJ; Pinto Rde S; Iborra RT; Ferreira Gda S; Nakandakare ER; Machado UF; Correa-Giannella ML; Catanozi S; Passarelli M
    Lipids Health Dis; 2015 Sep; 14():109. PubMed ID: 26377330
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular mechanisms of cellular cholesterol efflux.
    Phillips MC
    J Biol Chem; 2014 Aug; 289(35):24020-9. PubMed ID: 25074931
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Future therapeutic directions in reverse cholesterol transport.
    Khera AV; Rader DJ
    Curr Atheroscler Rep; 2010 Jan; 12(1):73-81. PubMed ID: 20425274
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HDL functionality in reverse cholesterol transport--Challenges in translating data emerging from mouse models to human disease.
    Lee-Rueckert M; Escola-Gil JC; Kovanen PT
    Biochim Biophys Acta; 2016 Jul; 1861(7):566-83. PubMed ID: 26968096
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Liver ABCA1 deletion in LDLrKO mice does not impair macrophage reverse cholesterol transport or exacerbate atherogenesis.
    Bi X; Zhu X; Duong M; Boudyguina EY; Wilson MD; Gebre AK; Parks JS
    Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2288-96. PubMed ID: 23814116
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Shifting gears: liver SR-BI drives reverse cholesterol transport in macrophages.
    van der Velde AE; Groen AK
    J Clin Invest; 2005 Oct; 115(10):2699-701. PubMed ID: 16200207
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of the gut in reverse cholesterol transport--focus on the enterocyte.
    Lee-Rueckert M; Blanco-Vaca F; Kovanen PT; Escola-Gil JC
    Prog Lipid Res; 2013 Jul; 52(3):317-28. PubMed ID: 23608233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.